Bank of Montreal
VIR icon

Bank of Montreal’s Vir Biotechnology VIR Stock Holding History

Bank of Montreal’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399K Buy
39,128
+491
+1% +$4.67K ﹤0.01% 2591
2026
Q1 		$346K Buy
38,637
+1,811
+5% +$14.4K ﹤0.01% 2579
2025
Q4 		$222K Buy
36,826
+647
+2% +$3.85K ﹤0.01% 2783
2025
Q3 		$207K Sell
36,179
-4,917
-12% -$25.1K ﹤0.01% 2757
2025
Q2 		$207K Buy
41,096
+29,122
+243% +$156K ﹤0.01% 2788
2025
Q1 		$77.6K Buy
11,974
+1,938
+19% +$17.2K ﹤0.01% 2971
2024
Q4 		$73.7K Sell
10,036
-1,539
-13% -$12.1K ﹤0.01% 3028
2024
Q3 		$87.2K Sell
11,575
-2,749
-19% -$23.9K ﹤0.01% 3284
2024
Q2 		$132K Sell
14,324
-6,561
-31% -$62.9K ﹤0.01% 3163
2024
Q1 		$212K Buy
20,885
+6,213
+42% +$63.3K ﹤0.01% 3017
2023
Q4 		$151K Sell
14,672
-719
-5% -$6.57K ﹤0.01% 3247
2023
Q3 		$151K Buy
15,391
+3,842
+33% +$54.8K ﹤0.01% 3163
2023
Q2 		$292K Sell
11,549
-1,090
-9% -$27.4K ﹤0.01% 2965
2023
Q1 		$337K Buy
12,639
+2,456
+24% +$62.8K ﹤0.01% 2710
2022
Q4 		$271K Sell
10,183
-90
-0.9% -$2.21K ﹤0.01% 2973
2022
Q3 		$308K Buy
10,273
+2,132
+26% +$54.2K ﹤0.01% 2919
2022
Q2 		$217K Buy
+8,141
New +$190K ﹤0.01% 3230
2021
Q4 		– Sell
-205,896
Closed -$8.93M – 3906
2021
Q3 		$8.93M Buy
+205,896
New +$8.91M ﹤0.01% 1355
2021
Q2 		– Sell
-1,632
Closed -$73K – 4916
2021
Q1 		$73K Sell
1,632
-7,382
-82% -$398K ﹤0.01% 3544
2020
Q4 		$254K Buy
9,014
+6,101
+209% +$198K ﹤0.01% 3090
2020
Q3 		$121K Sell
2,913
-973
-25% -$41.9K ﹤0.01% 2983
2020
Q2 		$184K Buy
3,886
+3,492
+886% +$117K ﹤0.01% 2774
2020
Q1 		$12K Sell
394
-511
-56% -$13.7K ﹤0.01% 3435
2019
Q4 		$11K Buy
+905
New +$12.1K ﹤0.01% 4546

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of Montreal's VIR Position: Q2 2026 in Review

Bank of Montreal increased its Vir Biotechnology (VIR) stake by 1.3% in Q2 2026, buying an estimated $4.67K and bringing the position to 39,128 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

Bank of Montreal first reported a position in VIR in Q4 2019 and has held it in 24 quarters since. The position peaked at $8.93M in Q3 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Bank of Montreal held 39,128 shares of Vir Biotechnology worth $399K as of Q2 2026.
  • Bank of Montreal bought 491 Vir Biotechnology shares in Q2 2026, an estimated $4.67K.
  • Vir Biotechnology made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2591 holding.
  • Bank of Montreal first reported a position in Vir Biotechnology in Q4 2019 and has held it in 24 quarters since.
  • Bank of Montreal's Vir Biotechnology position peaked at $8.93M in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.